. Author manuscript; available in PMC: 2013 Jun 27.

Published in final edited form as: Neuropsychopharmacology. 2009 Jun 24;34(11):2459–2468. doi: 10.1038/npp.2009.68

Table 2.

Effect of WAY100635 on Hippocampal VEGF Protein Levels in Animals Subjected to CUS and Fluoxetine Treatment

Treatment	VEGF protein levels pg/mg
CTR	12.6 ± 0.7
CUS	12.0 ± 0.5
CUS+FLX	15.4 ± 0.9**
CUS+FLX+WAY100635	13.2 ± 0.6^#

Fluoxetine and WAY100635 were administrated as described in the ‘Materials and Methods’ and levels of hippocampal VEGF were determined by ELISA. Results are expressed as mean±SEM pg VEGF/mg total protein. CTR, control; CUS, chronic unpredictable stress; FLX, fluoxetine. n= 6 per group.

<0.01 compared with CUS

<0.05 compared with CUS + FLX (ANOVA and Fisher’s post hoc test).